Target site insensitivity occurs when the molecular target of a toxicant undergoes structural changes that reduce binding affinity. This mechanism is common in pesticide resistance, where mutations in the target protein prevent the pesticide from exerting its toxic effect. In cancer treatment, similar mutations can lead to drug resistance, necessitating the development of new therapeutic strategies.
